Next Article in Journal
Study of the Sensing Kinetics of G Protein-Coupled Estrogen Receptor Sensors for Common Estrogens and Estrogen Analogs
Next Article in Special Issue
Risk Assessment of Trigonelline in Coffee and Coffee By-Products
Previous Article in Journal
Rhodium-Catalyzed Trans-Bis-Silylation Reactions of 2-Ethynyl-3-pentamethyldisilanylpyridines
Previous Article in Special Issue
Chemical, Nutritional and Biological Evaluation of a Sustainable and Scalable Complex of Phytochemicals from Bergamot By-Products
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluating the Probiotic Potential of Lactic Acid Bacteria Implicated in Natural Fermentation of Table Olives, cv. Cobrançosa

by
Joana Coimbra-Gomes
1,2,
Patrícia J. M. Reis
1,2,
Tânia G. Tavares
1,2,
Miguel A. Faria
3,
F. Xavier Malcata
1,2,* and
Angela C. Macedo
1,2,4
1
LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal
2
ALiCE—Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal
3
LAQV/REQUIMTE, Laboratory of Food Science and Hydrology/Rede de Química e Tecnologia, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal
4
UNICES-UMAIA—Research Unit in Management Sciences and Sustainability, University of Maia, Av. Carlos Oliveira Campos, 4475-690 Maia, Portugal
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(8), 3285; https://doi.org/10.3390/molecules28083285
Submission received: 10 March 2023 / Revised: 3 April 2023 / Accepted: 4 April 2023 / Published: 7 April 2023
(This article belongs to the Special Issue Advances in Functional Foods)

Abstract

:
The probiotic features of Lactiplantibacillus (L.) pentosus and L. paraplantarum strains, endogenous in Cobrançosa table olives from northeast Portugal, were assessed in terms of functional properties and health benefits. Fourteen lactic acid bacteria strains were compared with Lacticaseibacillus casei from a commercial brand of probiotic yoghurt and L. pentosus B281 from Greek probiotic table olives, in attempts to select strains with higher probiotic performances than those references. For functional properties, the i53 and i106 strains, respectively, exhibited: 22.2 ± 2.2% and 23.0 ± 2.2% for Caco-2 cell adhesion capacity; 21.6 ± 7.8% and 21.5 ± 1.4% for hydrophobicity; 93.0 ± 3.0% and 88.5 ± 4.5% for autoaggregation ability by 24 h of incubation; and ability to co-aggregate with selected pathogens—from 29 to 40% to Gram+ (e.g., Staphylococcus aureus ATCC 25923 and Enterococcus faecalis ATCC 29212); and from 16 to 44% for Gram− (e.g., Escherichia coli ATCC 25922 and Salmonella enteritidis ATCC 25928). The strains proved to be resistant (i.e., halo zone ≤14 mm) to some antibiotics (e.g., vancomycin, ofloxacin, and streptomycin), but susceptible (i.e., halo zone ≥ 20 mm) to others (e.g., ampicillin and cephalothin). The strains exhibited health-beneficial enzymatic activity (such as acid phosphatase and naphthol-AS-BI-phosphohydrolase), but not health-harmful enzymatic activity (such as β-glucuronidase and N-acetyl-β-glucosaminidase). Additionally, the antioxidant activity and cholesterol assimilation features, respectively, of the strains were 19.6 ± 2.8% and 77.5 ± 0.5% for i53, and 19.6 ± 1.8% and 72.2 ± 0.9% for i106. This study indicated that the addition of L. pentosus strains i53 and/or i106 to Cobrançosa table olives is likely to enhance the added value of the final product, in view of the associated potential benefits upon human health.

1. Introduction

The food industry has grown recently in response to consumer demand for higher quality food and food bearing positive effects upon human health. The latter belongs to the so-called family of “functional foods”—defined as matrices with the addition of nutraceutical ingredients, or subjected to minimum food processing to enhance bioactivity, but always providing health benefits beyond the provision of essential nutrients if regularly consumed as part of a balanced diet [1]. One example is food containing probiotics—i.e., viable microorganisms that, if ingested to appropriate levels, can exert several beneficial effects upon human health [2]. This is a dynamic field of endeavour [3], encompassing studies of probiotic potential of strains, ranging from native strains in traditional cheeses [4,5] to fish intestinal microbiota [6]. As per the high demand for probiotic products of non-dairy origin, researchers have explored survival and stability of probiotic strains in fruit, vegetable, cereal, meat, and soy food matrices. For instance, use of meat as a vehicle helps probiotic bacteria face adverse processing conditions due to its high fat content; use of fruits as vectors takes advantage of their unique physiology as effective environmental protectants of probiotic microorganisms—namely in the reduction in exposure to severe gastrointestinal conditions—further enhancing proliferation due to their high sugar content. It is also important to note that probiotic stability is highly dependent on the microorganism strain vs. processing parameters—e.g., the low pH of fruit juices favours survival of lactobacilli when compared to bifidobacteria, while the fibre present in cereals promotes growth of bifidobacteria. Table olives represent a unique form of delivery, integrating high fibre content with high fat content—thus conveying a hybrid medium of meaty and fruity features [7]. They are one of the oldest fermented foods and are an integral component in the Mediterranean diet.
Despite bearing a regional economic significance, table olive fermentation is still craft-based and empirically driven by its autochthonous microbiota. As an essentially spontaneous process, the quality of the final product hinges critically on various intrinsic and extrinsic factors, hence unpredictable and variable quality are commonplace [8,9]. Although a few nonconventional microorganisms have shown promising features toward food fermentation, comprehensive research efforts are still needed. The most important challenges concerning probiotic properties of microorganisms implicated in natural fermentation are safety issues, high cost, lack of process standardization, satisfaction of regulatory frameworks, and lack of detailed knowledge of their functionality in actual food products [10,11].
Among the multitude of microorganisms found during olive fermentation, Lactic Acid Bacteria (LAB) are the main bacteria responsible for brine acidification; this is due to their lactic acid production which leads to pH decrease, thus contributing to microbiological stability in the final product and extended shelf life. Oftentimes, LAB are candidates as potential probiotic microorganisms for withstanding the adverse conditions prevailing in the human gastrointestinal tract, prior to colonizing the gut [8,12]. Certain probiotic LAB species are typically associated with cultivar, e.g., Lactobacillus parafarraginis with Manzanilla [13], or L. paraplantarum with Kalamata and Conservolea [14], or Tonda di Cagliari [15]. To date, more than 40 species belonging to nine genera of LAB have been identified [16]; the genus most often cited is Lactobacillus, with L. plantarum and L. pentosus as the most frequent species—irrespective of country, processing method, or olive type. Examples of such probiotic LAB strains include those isolated from olives in Cyprus, Greece, Italy, Morocco, Portugal, and Spain [16,17]. In Portugal specifically, cultivars Galega [18] and Negrinha do Freixo [19,20] have already been studied in this regard, although the latter currently holds a Protected Designation of Origin [21]; recent interest has arisen in cultivar Cobrançosa—originated in Mirandela in northern Portugal, and widely known for its unique sensory features and long shelf life. Several relevant probiotic traits appear to be strain-specific, thus compromising straightforward extrapolation (even within the same species) from previous studies [22,23]; this realization helps justify the timeliness and relevance of this study.
Cobrançosa table olives undergo a two-stage processing: (i) sweetening stage—table olives are washed periodically with spring water of different proportions, and kept thereafter in water or brine with low salt content (up to 4%) for 4–6 months; and (ii) salting stage—salt is gradually added to the brine, up to 7–10% (w/w), but water/brine is no longer changed until the product is ready for market (up to 11 months) [24].
Overall, the main goal of this study was to evaluate the probiotic potential of 14 selected Lactoplantibacillus strains isolated from Cobrançosa cultivar. This was achieved by running tests that were split into two categories: functional properties—related to (expected) strain performance along the human gastrointestinal tract, thus critical to ascertain their chance of exerting a probiotic function once in the colon; and health benefits—associated with specific bioactivities exhibited in vitro, thus likely to also be present in vivo in the colon. The study of the probiotic potential of LAB will eventually allow for development of a starter or adjunct culture with commercial expression, specifically adapted to fermentation of Cobrançosa olives. By doing so, a final product of higher quality is anticipated—bearing improved functional properties in addition to their pre-existing sensory and nutritional features. Therefore, probiotic Cobrançosa table olives will likely reach a premium price in the modern food market, thus contributing to sustainable socio-economic and industrial development of the northern region of Portugal.

2. Results

2.1. Functional Properties

The results pertaining to functional properties, such as adhesion to Caco-2 cells, hydrophobicity, autoaggregation, and co-aggregation, for the 14 LAB native strains (belonging to genus Lactiplantibacillus (L.), and species L. paraplantarum and L. pentosus, previously collected from Cobrançosa table olive brines [24]) (see Table 1), additionally of two probiotic reference strains (from animal and plant sources), are tabulated in Table 2 and Table 3.

2.1.1. Caco-2 Cell Adhesion

Statistical differences between LAB cultures were found at the 5% level of significance (see ANOVA p-value in Table 2). For instance, strain i106 exhibited the highest value of Caco-2 cell adhesion (denoted by superscript a), which was statistically similar to that of strain i53 (also denoted by superscript a), but statistically different from the others (accordingly lacking superscript a). Comparatively, strain i24 exhibited the lowest value of Caco-2 cell adhesion (denoted by superscript i), which was statistically similar to that of strains i21, i26, i32, i34, and i108 (also denoted by superscript i), but statistically different from the others (accordingly lacking superscript i). Upon comparison of our results of adhesion to those encompassing the strain isolated from Greek table olives, it was concluded that strains i106, i53, and i101, exhibit similar performance—with scores of 23, 22, and 19%, respectively. Conversely, strains i21, i24, i32, i34, and i108, exhibited adhesion significantly lower than the yoghurt probiotic strain, viz. 6.2, 5.3, 6.0, 6.1, and 4.8%, respectively. The other strains displayed significantly higher adhesion than that of commercial probiotic yoghurt, but lower than that of Greek olives.

2.1.2. Hydrophobicity

Statistical differences between LAB cultures were found at the 5% level of significance (see ANOVA p-value in Table 2). Both reference strains performed similarly with regard to hydrophobicity—27 and 32% for yoghurt and table olives, respectively; most tested strains exhibited, in general, behaviours similar to those of the reference strains. Strain i21 showed significantly higher hydrophobicity (56%, denoted by superscript a), followed by strain i32 (41%, denoted by superscript b); whereas lower hydrophobicity was recorded for four strains—i19 (16%), i101 (19%), i112 (19%), and i108 (21%) (all denoted by superscript de).

2.1.3. Autoaggregation

At the 5% level of significance (see ANOVA p-values in Table 2), no statistical differences between LAB cultures were apparent by 5 h, but the reverse occurred by 24 h. For instance, strain i53 exhibited the highest value of autoaggregation value by 24 h of incubation (ca. 93%, denoted by superscript a), whereas i22 exhibited 59% as the lowest value of autoaggregation (denoted by superscript d); the other strains exhibited autoaggregation performance statistically similar to the commercial yoghurt strain (denoted by superscript abcd).

2.1.4. Co-Aggregation with Pathogens

Of all combinations of LAB and pathogenic strains assessed, co-aggregation ranged from 16% pertaining to strain i53 and S. enteritidis, to 46% pertaining to strain i26 and C. albicans (see Table 3). However, no significant differences were perceived between our strains and the reference strains.

2.1.5. Relationship between Functional Properties

Figure 1 shows a PCA applied to the functional properties of potential probiotic strains, such as Caco-2 cell adhesion, autoaggregation by 24 h, and hydrophobicity (autoaggregation by 5 h and co-aggregation were not considered, as per previous findings in the similarity among strains). The KMO measure of 0.586 confirmed that sampling size was adequate to apply factor analysis—with variables exhibiting significant correlation to each other, according to Bartlett’s test of sphericity (p = 0.041). Two components were accordingly selected from the scree plot (Figure 1) and were able to justify 78% of total variance. Component 1 is highly correlated to autoaggregation (C1: 0.902, C2: 0.084), while component 2 is highly correlated to adhesion (C1: −0.0190; C2: 0.947); hydrophobicity (C1: −0.677; C2: −0.529) appears to correlate negatively with both components. Inspection of Figure 2a and Figure 3a indicates that hydrophobicity appears in opposite direction to adhesion and autoaggregation, respectively. Inspection of Figure 2a shows that adhesion correlates with a major part of RAPD profiles (lep104, lep205a, and lep205b); based on the plots of scores (Figure 2b), the cluster containing i17, i22, i23, i53, and i106, emerged from all three clusters—as expected, in view of their RAPD profiles (see Table 1). Figure 3a indicates that strains with higher adhesion performance can be typically found in the final stages of sweetening (111 d) and brining (329 d); Figure 3b also shows that the cluster formed by i17, i24, i53, i101, i106, and i108, is related to that of processing times (see Table 1).

2.2. Health Benefits

The results pertaining to potential health benefits upon the human being, regarding the 14 LAB native strains from Cobrançosa and two probiotic reference strains (from animal and plant sources), are depicted in Table 4 and Table 5.

2.2.1. Antibiotic Resistance

All native LAB cultures assessed exhibited resistance to vancomycin, ofloxacin, and streptomycin; and susceptibility to ampicillin, erythromycin, tetracycline, chloramphenicol, and cephalothin (see Table 4). Strain i112 and the yoghurt control strain exhibited intermediate resistance to ofloxacin, yet their inhibition zones were very close to the “Resistant score” (i.e., halo ≤ 14 mm). Therefore, the resistances of our strains were quite similar to those of either reference strain.

2.2.2. Antimicrobial Activity

Every LAB culture presented no significant inhibition halo around the well when neutralized cell-free supernatant was added. However, blurred halos were observed when the acidic CFS (cell-free supernatant) was used.

2.2.3. Antioxidant Activity

Statistical differences between LAB cultures were found at the 5% level of significance (see ANOVA p-value in Table 5); results ranged from 18% (strain i23) to 23% (strain i19). Additionally, the antioxidant activities of all our strains (except i22 and i23) were statistically higher (denoted by superscripts a or ab) than those of the reference strains, viz. 18% and 13% for yoghurt (denoted by superscript bc) and Greek olives (denoted by superscript cb), respectively.

2.2.4. Cholesterol Assimilation

Statistical differences between cholesterol content of LAB cultures were found at the 5% level of significance (see ANOVA p-value in Table 5). Strain i23 presented the highest cholesterol assimilation percentage (83%, denoted by superscript a), despite statistical equivalence to all strains except i24, i101, i17, i108, and i32; the lowest assimilation was exhibited by the latter (68%, denoted by superscript e). All LAB strains exhibited significantly higher values than that of the yoghurt reference strain—53% (denoted by superscript f). Compared to the Greek reference strain—77% (denoted by superscript abcd)—all strains presented significantly equivalent percentages of cholesterol assimilation.

2.2.5. Proteolytic Activity

All studied strains showed proteolytic activity, detected by clear zones around the colonies (see Table 5). Such zones were not identical for all strains, yet the variations in diameter were sufficiently small to merit report.

2.2.6. EPS Production

All strains of L. pentosus, except i32, tested positive for EPS production—as per the appearance of white colonies; a positive result was found only for L. paraplantarum strain i21 (see Table 5).

2.2.7. Enzymatic Activity

As shown in Table 6, all LAB strains exhibited high activities of aminopeptidase (regarding leucine arylamidase and valine arylamidase), acid phosphatase, naphthol-AS-BI-phosphohydrolase, β-galactosidase, and α-glucosidase; β-glucosidase activity was recorded as high for all strains, except the yoghurt reference strain. No strains exhibited lipase, trypsin, α-chymotrypsin, β-glucuronidase, N-acetyl-β-glucosaminidase, α-manosidase, or α-fucosidase activities. All strains, except i21, i17, i22, i23, i34, and i106, presented high esterase and lipase/esterase activities. Regarding the yoghurt reference strain, these two activities were found to be high, while the Greek strain exhibited low activities. Finally, α-galactosidase activity was recorded as low for strains i21, i17, i22, i23, i34, i106, and the Greek strain; and was absent in the other strains. The same strains possessed no alkaline phosphatase activity—similarly to the reference strains, and unlike the remainder (with low activities).

3. Discussion

Adhesion performance to Caco-2 cells in vitro—which mimics in vivo epithelial adhesion on the colon—is crucial for a microorganism to exhibit a probiotic effect. Probiotics must anchor in the colon to exert their action and provide an opportunity to interact with local bacteria and the host’s own cells. The results of our strains (from 1% to 23%) are similar to those of Luz et al. [25], with values between 3% and 19%, and of Maragkoudakis et al. [26], ranging from 0.2% to 25.5%; the latter considered adhesion capacity above 13% to be sufficient.
The ability of bacteria to stick to hydrocarbon moieties constrains their extent of adhesion to epithelial cells in the colon, known as cell surface hydrophobicity [27]; the higher the hydrophobicity, the higher the adherence ability [28]. The values of hydrophobicity of our strains in contact with xylene, as model hydrocarbon, varied significantly among them—16–56%; likewise, Abouloifa et al. [17] reported viz. 15–35%. Similar to Benítez-Cabello et al. [29], our study was directed at an opposite relation between hydrophobicity and adhesion to cell lines. This is, probably, a consequence of the fact that attachment to surfaces depends not only on hydrophobicity of the cell surface, but also on Brownian movement, van der Waals attraction, and surface electrostatic charges. Another explanation is the possibility that microorganisms switch between hydrophobic and hydrophilic phenotypes, in response to changes in environmental conditions and growth phases [29]. Motey et al. [30] and Joghataei et al. [31]—who also found a peculiar anticorrelation—claimed that electrostatic power and cell surface charges originating from proteins, glycoproteins, teichoic and lipoteichoic acids, and exopolysaccharides on the cell wall, may in fact be expressed differently from strain to strain [32].
The data of autoaggregation performance by 5 h of incubation, viz. 19–32%, were similar to those of Abouloifa et al. [17], viz. 10–41%; whereas data collected by 24 h of incubation, viz. 59–93%, presented similarities to those of Margalho et al. [4], viz. 69–99%. Reasoning for having tested those two incubation times arises from the experimental conditions selected among similar studies, e.g., 5 h [17,33] or 24 h [34,35]. However, the former appears to not be sufficiently discriminatory between strains. Autoaggregation ability ensures that the probiotic strain reaches a high cell density in the gut, thus contributing to the adhesion mechanism by forming a protective barrier on the intestinal mucosa and epithelial cells, and promoting temporary settlement [4,36].
Co-aggregation of a strain with a pathogen is expected to play an important role in its elimination from the gastrointestinal tract—namely, via formation of a barrier that prevents colonization by pathogenic bacteria, and enhances production of antimicrobial substances [31,37]. Our values for co-aggregation with pathogenic strains ranged from 16 to 45%. These results agree with Luz et al. [25], viz. 9–31% for LAB strains vs. Escherichia coli, Salmonella enterica, and Listeria monocytogenes; with Joghataei et al. [31], viz. 28–37% vs. E. coli and 25–51% vs. Salmonella typhimurium; and with Peres et al. [18], viz. 10%–50% vs. E. coli, S. aureus, S. typhimurium, L. monocytogenes, and Helicobacter pylori. Regarding Candida albicans, similar results were reported by Jørgensen et al. [38]. Despite consistent results, this test failed to differentiate between strains, given their statistical similarity.
Resistance towards antibiotics associated with probiotic food consumption—together with evidence of horizontal gene transfer from beneficial bacteria to pathogenic bacteria in host’s gut [36]—has become a public health concern; this accordingly justified inclusion of this test in our study. Resistance of our strains to streptomycin and vancomycin, and susceptibility to chloramphenicol, have also been reported by Ozkan et al. [28]; susceptibility to erythromycin, ampicillin, chloramphenicol, and cephalothin, as well as resistance to vancomycin, have also been reported by Abouloifa et al. [17]. Ofloxacin resistance has been claimed by Zarour et al. [39]; Vergalito et al. [40] and Luz et al. [25] have shown susceptibility to tetracycline, as well. Regarding the other antibiotics, our results did not always agree with the literature—probably due to strain-dependent behaviours [40]. Absence of antibiotic resistance has been outlined in FAO/WHO probiotic selection guidelines as a crucial safety parameter, as reported by Ozkan et al. [28]. Transmissible resistance to antibiotics, e.g., to tetracycline encoded by host mobilizable plasmids, would be a threat; however, our strains did not convey this [39]. Although resistance to vancomycin has been recorded, it is known to be intrinsic and due to chromosomal genes, with no expected transfer of antibiotic resistant genes from LAB to pathogens; furthermore, Ozkan et al. [28] showed that resistance to vancomycin and streptomycin is naturally present in LAB strains, rather than acquired through gene transfer. Therefore, the risk of lactobacillemia caused by probiotic Lactobacillus has been considered unequivocally negligible [17]. Conversely, probiotic strains with intrinsic resistance to antibiotics may prove useful in restoring intestinal microbiota, following treatment therewith [39].
Antimicrobial activity against pathogens is deemed a desirable trait, although not mandatory for probiotic performance [41]. Our results did not support clear conclusions in this regard, consequently this test was discarded at early stages in the selection process of probiotic strains.
Antioxidant compounds produced by probiotics protect the human body against high levels of oxygen radicals—known to cause damage to lipids, proteins, and DNA—and accordingly help prevent many diseases, e.g., cardiovascular diseases, diabetes, and ulcers in the gastrointestinal tract [17,36]. Compared to data conveyed by Abouloifa et al. [17], viz. 43–93% (via the same method), our results were considerably lower, viz. 16–23%; comparatively, Oliveira et al. [20] reported even lower values, 3–17%. Ayyash et al. [42] claimed antioxidant values of 5–20% on the day of the experiment, depending on the strain; but an increasing trend until 21 days of incubation—when values ranged within 10–50%. Therefore, antioxidant activity may increase with residence time in the gut.
Recent discoveries have also linked probiotic ingestion to prevention of heart disease, by lowering serum levels of cholesterol and decreasing its solubility which reduces uptake in the gut [36]. Our study produced cholesterol assimilation values between 68 and 82%, thus revealing significantly higher percentages for all strains than those of the yoghurt control strain. Our values were higher than those of Vergalito et al. [40], viz. 20–50%, despite the use of similar methodology.
It is important that probiotic strains possess proteolytic activity, as this facilitates nutrient procurement once in the gastrointestinal tract; additionally, bioactive peptides may be produced [18,43]. Although all strains exhibited proteolytic activity, the qualitative data were not conclusive enough to support discrimination between them.
Another criterion for probiotic activity is EPS synthesis owing to secondary metabolites ability to increase quality and shelf life in fermented foods [36,44]; EPS production in our study was observed for most L. pentosus strains (except i32), but only one L. paraplantarum strain (i21). Abouloifa et al. [17] reported EPS production in Levilactobacillus (Lv.) brevis and L. plantarum strains; Ozkan et al. [28] in Lv. Brevis, L. plantarum, Lc. Paracasei, Loigolactobacillus coryniformis, Lc. Rhamnosus, and Lactobacillus helveticus; and Peres et al. [18] in L. plantarum and L. paraplantarum.
LAB strains presented a broad spectrum of enzymatic activities, yet our results were essentially similar to those in the literature [17,35]. β-glucosidase activity was high for all our strains, except the yoghurt reference strain; this was expected, as this enzyme is responsible for degrading oleuropein, a natural component of table olives. This activity is very important to remove natural fruit bitterness, or reduce the time needed in olive debittering—known to enhance food flavour and accelerate ripening [45,46,47]. Other enzymatic activities can enhance food flavour; some strains showed positive results for esterase and esterase/lipase, which support lipolyzed flavours. Other examples include α-glucosidase activity, which catalyses degradation of saccharose into sweeter fructose via hydrolysis of α-glycosidic linkages of the non-reducing end of oligosaccharides and polysaccharides [35]; and aminopeptidase activity, which plays an important role toward hydrolysis of bitter peptides, and concomitant release of amino acids [17,25]. Additionally, acid phosphatase and naphthol-AS-BI-phosphohydrolase activities were found to be high; in the human digestive system, both are necessary to free phosphoryl groups from other molecules during digestion, aside from improving food maturation [25,47]. Contrarily, some enzymes should be absent in probiotic strains. This is notably the case of N-acetyl-β-glucosaminidase activity, which may raise a safety concern for application in foods, as it releases toxic products, and transforms many pro-mutagens and pro-carcinogens into their mutagenic and carcinogenic forms, respectively [48]; in addition, being associated to the development of several gastrointestinal diseases [40,49]. Furthermore, trypsin, α-chymotrypsin, and β-glucuronidase, are also associated with intestinal diseases [17], thus should be absent in potential probiotic strains. Low activities toward carbon sources such as α-mannose and α-fucosidase, as well as high β-galactosidase and α- and β-glucosidase activities, suggest that our strains have a preference for lactose and glucose as carbon and energy sources [47]. Alkaline phosphatase (responsible for dephosphorylation) and lipase (bearing lipolytic activity) activities were quite low, even absent, in our strains. β-Galactosidase activity was found to be high among our strains and is relevant for its ability to alleviate the symptoms of lactose intolerance following dairy product ingestion, or intolerance to galactooligosaccharides that serve as specific nutrients to probiotics already established in the gut [25].
In attempts to select the best adventitious (potentially) probiotic strain in Cobrançosa, analysis should depart from the functional properties of the strains under scrutiny. LAB isolates bearing low values for hydrophobicity exhibited high values for adhesion and autoaggregation, and vice versa. The variable hydrophobicity is thus redundant, consequently it was not considered as a selection criterion.
The best candidates to probiotic LAB strains, based on functional properties that include RAPD profiles, are i17, i22, i23, i53, and i106. Considering Margalho et al. [4] labelled 24 h-aggregation percentages as “high” when above 70%, and “moderate” if between 20% and 70%, our strains i17, i23, i53, and i106, would accordingly rank as high, unlike strain i22 (59%). Therefore, we decided to discard i22 as a best candidate for a probiotic culture tailor-designed in the addition to Cobrançosa table olives in a future standardized process.
The best candidates to probiotic LAB strains, based on functional properties including processing time, were strains i17, i24, i53, i101, i106, and i108; this is probably a consequence of ecological dominance of the most resistant strains by the final time of each stage.
Of the two aforementioned analyses regarding functional properties, the isolates selected for further consideration were i17, i53, and i106. This selection is consistent with Table 2, as these isolates exhibited good values for autoaggregation (84, 93, and 89%, respectively); the same did not occur with adhesion (14, 22, and 23%, respectively), for which i17 exhibited significantly lower adhesion performance. Therefore, strain i17 was discarded on statistical grounds, thus leaving only i53 and i106 as statistically identical for both criteria.
The next screening step relied on health benefit features, as per in vitro assessment. Antibiotic resistance and proteolytic activity could not be used as criterion since performance of isolates were very similar to each other (Table 4). The isolates i53 and i106 produced EPS (+), exhibited antioxidant performance (ca. 20%), and cholesterol assimilation (ca. 78.5%), statistically equivalent to each other (see Table 5); hence, no strain was discarded from further analysis based on these criteria. Finally, such isolates revealed positive activity of advantageous enzymes (see Table 6): aminopeptidases, acid phosphatase, naphthol-AS-BI-phosphohydrolase, β-galactosidase, and α- and β-glucosidase; along with negative results pertaining to enzymes associated with safety concerns for human health: trypsin, α-chymotrypsin, β-glucuronidase, and N-acetil-β-glucosaminidase.
Since differences were not substantial between strains, i53 and i106 remained the best candidates as a starter or adjunct culture possessing a high probiotic potential—on average, gathering the best probiotic features. Finally, the addition of strain i106 to Cobrançosa table olives had previously been tested in loco (at pilot scale) to ascertain its viability and effects upon the technological, microbiological, and physicochemical profiles along the fermentation process, as well as upon the sensory features thereof. Such experiments were run in parallel with a control using only the spontaneous microflora and supported the conclusion that it is technologically feasible to use those potentially probiotic strains as additives, without compromising the expected quality of the final product [50]. However, addition of that strain is likely to enhance the added value of the final product, for the associated potential benefits upon human health.

4. Materials and Methods

4.1. Bacterial Strains and Growth Conditions

Fourteen LAB strains belonging to genus Lactiplantibacillus, and species paraplantarum and pentosus were tested in this study (see Table 1); they were previously collected from Cobrançosa table olive brines [24]. These strains were identified by combining RAPD-PCR and 16S rRNA sequencing, according to the method described by Reis et al. [24]; 16S rRNA sequences of these strains were deposited in the NCBI GenBank database, under convenient accession numbers (see Table 1) [51].
In our laboratory, they were first screened for technological characteristics (i.e., ability to survive/grow at different salt concentrations, ability to survive/grow at high and low pH, capacity to degrade/assimilate oleuropein, and tendency to produce CO2) (unpublished data); food safety features (i.e., mucin degradation ability, and haemolytic and DNase activities); and gastrointestinal survival. Such strains, stored in 15% glycerol at −80 °C, when not in use, were revived in Man, Rogosa, and Sharpe (MRS) agar (VWR Chemicals, Leuven, Belgium), at 30 °C for 48 h, then maintained at 4 °C for upward of one week. Prior to the experiments, they were subcultured in MRS broth (VWR), at 30 °C for 15 h, without shaking (i.e., overnight incubation), to attain the stationary phase. A strain of Lacticaseibacillus (Lc.) casei isolated from a well-known commercial brand of probiotic yoghurt was used as the probiotic reference strain; in addition, a Lactiplantibacillus (ex. Lactobacillus) pentosus strain B281 bearing probiotic properties, previously isolated from Greek table olives, kindly provided by the Laboratory of Microbiology and Biotechnology of Foods, Department of Food Science and Human Nutrition, Agricultural University of Athens [8].

4.2. Strain Selection Based on Functional Properties

4.2.1. Caco-2 Cell Adhesion

The method of Argyri et al. [52] was hereby followed. Caco-2 cells (2 × 105) (from European Collection of Cell Cultures, n. 86010202) were seeded in 12-well plates with Dulbecco’s modified Eagle’s medium—composed of 2 mM glutamine, 1% (w/v) nonessential amino acids, and 20% (v/v) fetal bovine serum, supplemented with 100 U/mL penicillin/streptomycin (Sigma Aldrich, St. Louis, MO, USA). Medium in the wells was replaced by fresh medium every 2–3 days, and monolayers maintained for 13 days in 7% CO2 at 37 °C until lack of further (visible) differentiation. Before proceeding to Caco-2 monolayers, the growth medium in the tissue culture plates was withdrawn, cells were washed twice with 3 mL of Phosphate-Buffered Saline (PBS, i.e., 10 mM Na2HPO4, 1 mM KH2PO4, 137 mM NaCl, and 2.7 mM KCl (VWR), pH 7.2), and incubated at 37 °C for 1 h with 2 mL of RPMI-1640 without serum or antibiotics. Before performing the adhesion assay, all bacterial cultures were grown overnight until the stationary phase in MRS at 37 °C, centrifuged for 10 min at 4 °C and 3211× g (Model 1580R, GYROZEN, Gimpo, Korea), washed twice with sterile PBS, and finally diluted in RPMI-1640 medium (without serum or antibiotics) to 107 CFU/mL. Subsequently, 1 mL of bacterial RPMI suspension was added to each well (technical replicates), with each strain being assessed for adherence in triplicate for each experiment. Following co-incubation for 2 h at 37 °C under 5% CO2/95% air, the medium was removed, and the monolayer washed three times with 1 mL of sterile PBS. The Caco-2 cells were detached with 2 mL of 1% of Triton X-100 (v/v) (Sigma Aldrich, St. Louis, MO, USA) in PBS. Following incubation for 5 min at 37 °C, cell lysates were serially diluted and plated on MRS agar. The experiments were repeated three times (biological replicates) for all strains. Adherence performance, expressed as percentage, Ad(%), was calculated via Equation (1):
A d ( % ) = ( C F U f C F U i ) × 100
where CFUf = number of bacterial cells that remained attached and CFUi = total number of bacterial cells initially added to each well.

4.2.2. Hydrophobicity

The hydrophobicity of the strain cell surface was evaluated by measuring cell adhesion to hydrocarbons such as o-xylene. As described by Abouloifa et al. [17], overnight cultures were centrifuged (3211× g, 10 min, 5 °C), washed twice in sterilized PBS, and re-suspended in 0.1 M sterilized KNO3 (VWR) to an optical density at 600 nm, adjusted to 108 CFU/mL. Next, 3 mL of cell suspension was mixed with 1 mL of o-xylene (Sigma Aldrich), and the mixture left at room temperature (25 °C) for 10 min. It was then vortexed for 2 and 20 min to promote phase separation. The aqueous phase was collected, and its absorbance recorded at 600 nm. This assay was performed in triplicate for all strains (biological replicates). The cell surface hydrophobicity was expressed as percentage, H(%), using Equation (2):
H ( % ) = ( 1 O D f O D i ) × 100
where ODi = optical density at start of assay and ODf = optical density at end of assay.

4.2.3. Autoaggregation

Following Abouloifa et al. [17], LAB cultures were harvested by centrifugation (3211× g, 10 min, 5 °C), after overnight incubation in MRS broth at 30 °C. The pellet was washed twice and re-suspended in PBS to obtain 108 CFU/mL. The initial absorbance at 600 nm was measured, and the bacterial suspension was then incubated at 30 °C for 5 h. An aliquot was collected from the surface of the sample, and its absorbance measured at 600 nm; this measurement was repeated by 24 h. All aforementioned experiments were repeated three times (biological replicates) for all strains. Autoaggregation performance was expressed as percentage, A(%), according to Equation (3):
A ( % ) = ( 1 O D f O D i ) × 100
where ODi = optical density measured at start of assay (time 0) and ODf = optical density measured at end thereof (by 5 or 24 h).

4.2.4. Co-Aggregation

The methods by Montoro et al. [53] and Taheur et al. [54] were followed. LAB cultures were incubated overnight in MRS broth at 30 °C, without agitation. The pathogenic strains were incubated at 37 °C with agitation, in appropriate media: Bacillus cereus ATCC 11778 in Tryptic Soy broth with Yeast extract (TSY, VWR); Candida albicans ATCC 10231 in Yeast extract Peptone Dextrose broth (YPD, VWR); Escherichia coli ATCC 25922 and Salmonella enteritidis ATCC 25928 in Luria Broth (LB, VWR); and Enterococcus faecalis ATCC 29212, Listeria innocua ATCC 33090, and Staphylococcus aureus ATCC 25923 in Brain Heart Infusion (BHI, VWR). All cultures were harvested by centrifugation (3211× g, 10 min, 5 °C), washed and re-suspended in PBS, and adjusted to 108 CFU/mL. Then, 2.4 mL of a LAB suspension was mixed to 2.4 mL of pathogen suspension. As controls, 4.8 mL of each LAB strain, and 4.8 mL of each pathogenic strain were used. Absorbance at 600 nm of each bacterial suspension was measured at time 0. By 24 h of incubation at 37 °C, absorbance of the upper suspension was recorded. This assay was performed in triplicate for all strains (biological replicates). Co-aggregation performance, CA (%), was calculated via Equation (4):
C A ( % ) = [ ( O D t O D t 0 ) m i x ( ( O D t O D t 0 ) L A B + ( O D t O D t 0 ) p a t ( O D t 0 ) L A B + ( O D t 0 ) p a t ) ] × 100
where ODt0 = optical density measured at start of assay and ODt = optical density measured at end of assay, for the “mix” (of lactic acid bacteria and a pathogenic strain), “LAB” (lactic acid bacteria)”, or “pat” (pathogenic strain).

4.3. Health Benefits

4.3.1. Antibiotic Resistance

Susceptibility to antibiotics was measured by the agar disc diffusion method, using representatives from different groups (e.g., β-lactams, aminoglycosides), and comprising diverse mechanisms of action (e.g., inhibition of cell wall, inhibition of protein synthesis). The final selection was 30 μg/mL of chloramphenicol, 30 μg/mL of tetracycline, 10 μg/mL of ampicillin, 30 μg/mL of cephalothin, 15 μg/mL of erythromycin, 10 μg/mL of streptomycin, 30 μg/mL of vancomycin, and 5 μg/mL of ofloxacin (Oxoid, Thermo Fisher, Basingstoke, UK). Our testing followed Abouloifa et al. [17] and Szutowska et al. [55], with modifications. Lactic acid bacteria revived in MRS agar were inoculated in ca. 3 mL of 0.85% NaCl solution, to obtain a bacterial suspension of 105 CFU/mL. Then, 1 mL of each bacterial suspension was pour-plated on MRS agar, and discs containing the antibiotics were deposited on the plates after 15 min of diffusion; these were incubated at 37 °C for 24/48 h. The results were consubstantiated by diameter of inhibition zone around each antibiotic disc and the strains were categorized based thereon. To ascertain reliability of antibiotic discs used, the same procedure was repeated for E. coli and S. aureus, pour-plated in Muller-Hinton agar (VWR).

4.3.2. Antimicrobial Activity

The agar well diffusion method of LAB cell-free MRS broth was followed, as per Abouloifa et al. [56] and Mulaw et al. [57]. For this assay, overnight cultures of LAB strains were incubated in MRS broth with 1% (w/v) glucose (D+; Sigma Aldrich) at 30 °C. The pathogenic strains and growth media were the same as for the co-aggregation ability test, including 37 °C and stirring. Overnight cultures were centrifuged (3211× g, 10 min, 5 °C), washed twice in sterilized PBS, and re-suspended in the same buffer. All bacterial pathogenic strains were seeded in Mueller Hinton agar, to an initial optical density of ca. 0.22 at 600 nm. Pathogenic yeast Candida albicans was seeded at an initial optical density of ca. 0.4 at 600 nm. Afterwards, each well was loaded with 100 μL of sterile CFS of LAB cultures and incubated at 30 °C for 24 h for bacteria, or 48 h for yeast. To compare the effect of pH on this assay, all LAB cultures CFS were also neutralized with NaOH (5 M; VWR) and pour-plated with pathogens. The qualitative result of this test was reported as inhibition zones of indicator strains around the wells.

4.3.3. Antioxidant Activity

To assess the antioxidant activity, the decrease in concentration of 1,1-diphenyl-2-picrylhydrazyl (DPPH; Sigma Aldrich) radical brought about by LAB strains was selected, following Abouloifa et al. [17]. LAB strains were grown overnight in MRS broth at 30 °C. The bacterial cells were harvested by centrifugation (3211× g, 10 min, 5 °C), and washed twice with a sterile solution of 0.9% NaCl; the resulting pellets were adjusted to 108 CFU/mL and re-suspended in the same solution. The cell suspension (0.5 mL) was transferred into a fresh tube, to which 1 mL of methanolic DPPH radical solution (0.1 mM) was also added. The mixture was mixed vigorously and incubated for 30 min at room temperature in the dark. The resulting solution was centrifuged at 9600× g (Model SorvallTM LegendTM Micro 17R, Thermo Fisher Scientific, Frankfurt, Germany) for 3 min at 5 °C; and 300 μL of the supernatant was then transferred into 96-well plates, to measure absorbance at 517 nm. The controls included plain sterile 0.9% NaCl and DPPH solution; the blanks contained only ethanol and cells. The experiments were repeated for all strains as three biological replicates, each with two technical replicates. To calculate the antioxidant activity AA(%), the percent reduction in DPPH was determined via Equation (5):
AA ( % ) = ( 1 O D s a m p l e O D b l a n k O D c o n t r o l ) × 100
where ODsample = optical density measurement of samples, ODblank = optical density measurement of blank (ethanol mixed with bacterial supernatant), and ODcontrol = optical density measurement of control (DPPH and distilled water solutions) by the end of the assay.

4.3.4. Cholesterol Assimilation

The selection of strains with lowering-cholesterol ability was performed by in vitro tests using water-soluble cholesterol, Cholesterol-PEG 600—polyoxyethylene cholesteryl sebacate (Sigma Aldrich)—and resorted to colorimetry, with a commercial kit for cholesterol quantification (Sigma Aldrich). According to Benítez-Cabello et al. [46], overnight cultures of LAB were centrifuged (3211× g, 10 min, 5 °C), washed twice with a 0.85% NaCl solution, and re-suspended in PBS. After 2 h at room temperature (to simulate starvation), 20 μL of suspension was inoculated in 200 μL of MRS broth and supplemented with 3 g/L of oxgall (Sigma Aldrich) and 0.100 g/L of cholesterol. After incubation at 37 °C for 24 h, samples were centrifuged (9600× g, 3 min, 5 °C) and pellet was discarded. The cholesterol was quantified according to manufacturer’s instructions, using a standard curve of absorbance at 500 nm vs. cholesterol concentration. MRS and oxgall without cholesterol solution were used as controls. The experiments were repeated for all strains as two biological replicates, each with two technical replicates. After knowing cholesterol concentration, according to said kit, cholesterol assimilation CA(%) was determined via Equation (6):
CA ( % ) = ( 1 C f C i ) × 100
where Ci = initial cholesterol concentration and Cf = final cholesterol concentration in the samples.

4.3.5. Proteolytic Activity

The proteolytic activity of isolates was assayed according to Peres et al. [18]. Overnight cultures were spot inoculated on skim milk agar, composed of 5 g/L casein (Sigma Aldrich), 2.5 g/L yeast extract (Merck), 1 g/L glucose (Sigma Aldrich), and 28 g/L skim milk. After 48 h of incubation at 37 °C, the clear zones around the colonies were checked and taken as indicator of proteolytic activity.

4.3.6. Exopolysaccharide (EPS) Production

The ruthenium red staining method, by Abouloifa et al. [17] and Anagnostopoulos et al. [58], was chosen to assess EPS synthesis. Starting with overnight cultures of LAB, 5 μL was deposited on the surface of plates containing ruthenium red milk medium composed of 0.5% yeast extract (Merck), 10% skim milk powder (Sigma Aldrich), 1% sucrose (Sigma Aldrich), 0.08 g/L ruthenium red (Sigma Aldrich), and 15 g/L bacteriological agar (VWR). The plates were incubated at 37 °C for 48 h, then colony colour was checked. Ruthenium red is a carbohydrate-binding dye used to stain biofilms formed by EPS-producing bacteria; as a result, the non-ropy strains should develop red colonies due to bacterial cell wall staining, while EPS strains should appear as white colonies.

4.3.7. Enzymatic Activity

The procedure followed to assay for enzymatic activity included API ZYM system (BioMérieux, Marcy-l’Étoile, France), for its coverage of a wide range of enzymes; the procedure was previously described by Abouloifa et al. [17] and Taheur et al. [54]. The overnight LAB cultures were centrifuged (3211× g, 10 min, 5 °C), washed, and re-suspended in 0.85% of NaCl solution, at initial optical density of 0.08 at 600 nm. Each well of API ZYM system was loaded with 65 μL of LAB suspension. After 4 h of incubation at 30 °C, reagents ZYM-A and ZYM-B were added to each well, according to manufacturer’s instructions [47]. The enzymatic activity was evaluated based on APY ZYM system scale, as per the manufacturer; the results were first graded from 0 to 5, depending on colour intensity developed within 5 min vis-à-vis with colour reaction chart; then, the values obtained (0–5) were approximately converted to nanomole of hydrolysed substrate (0–40). Each strain was tested three times with the API ZYM kit, to ensure reproducibility of experimental results.

4.4. Statistical Analysis

One-way analysis of variance (ANOVA), followed by Tuckey Post-Hoc, equates to multiple comparisons being performed for epithelial adhesion capacity, autoaggregation and co-aggregation abilities, hydrophobicity degree, antioxidant activity, and cholesterol assimilation tests—with the aid of IBM SPSS 27.0 software (IBM, Armonk, NY, USA), at the 5% level of significance. The same software was used for Principal Component Analysis (PCA) with oblique rotation (direct oblimin), applied to Caco-2 cell adhesion, autoaggregation, and hydrophobicity performance; as additionally, determination of Kaiser-Meyer-Olkin (KMO) measure to check that sample size was adequate for analysis, and Bartlett’s test of sphericity to unfold inter-correlations between variables. Furthermore, Canoco™ V5.0 (Microcomputer Power, Ithaca, NY, USA) was used to produce both plot of loadings and plot of scores from PCA applied to adhesion, autoaggregation and hydrophobicity, LAB RAPD profile, table olive fermentation time, and isolate identification.

5. Conclusions

All 14 strains of Lactiplantibacillus paraplantarum and Lactiplantibacillus pentosus tested, adventitious in Cobrançosa table olives, exhibited probiotic potential. Comparison with strains from a commercial brand of yoghurt or strains retrieved from Greek table olives unfolded a better performance of L. pentosus strains i53 and i106 in terms of functional properties. Antibiotic resistances were found to be intrinsic—thus discarding the possibility of (undesired) gene exchange with pathogens. The aforementioned strains were able to produce exopolysaccharides and exhibited antioxidant and cholesterol-decreasing activities—likely to bring health advantages to the host.
Limitations of this work were the assessment of antimicrobial and proteolytic activities—which proved not useful for screening, in view of the statistically similar results obtained; more quantitative analytical methodologies are thus recommended.
In future work, probiotic performance of L. pentosus i53 and/or L. pentosus i106 endogenous lactic acid bacteria strains should be confirmed by resorting to animal models; their inclusion in a starter culture or adjunct culture should be tested at pilot-scale, aiming at a more standardized commercial process.

Author Contributions

Conceptualization, P.J.M.R., F.X.M. and A.C.M.; methodology, P.J.M.R., T.G.T. and A.C.M.; validation, P.J.M.R., F.X.M. and A.C.M.; formal analysis, J.C.-G., P.J.M.R., T.G.T., M.A.F. and A.C.M.; investigation, J.C.-G., P.J.M.R., T.G.T. and A.C.M.; data curation, J.C.-G., P.J.M.R. and T.G.T.; writing—original draft preparation, J.C.-G.; writing—review and editing, F.X.M. and A.C.M.; visualization, J.C.-G. and P.J.M.R.; supervision, P.J.M.R., F.X.M. and A.C.M.; project administration, F.X.M.; funding acquisition, F.X.M. and A.C.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by: Project PROMETHEUS-POCI-01-0145-FEDER-029284, funded by FEDER funds through COMPETE2020—Programa Operacional Competitividade e Internacionalização (POCI) and by national funds (PIDDAC) through FCT/MCTES; and LA/P/0045/2020 (ALiCE), and UIDB/00511/2020 and UIDP/00511/2020 (LEPABE), funded by national funds through FCT/MCTES (PIDDAC); and UIDB/50006/2020 and UIDP/50006/2020 (LAQV/REQUIMTE), funded by national funds through FCT/MCTES. Joana Coimbra-Gomes was financially supported by a research grant under partnership agreement with the Faculty of Engineering of University of Porto, inserted in project PROMETHEUS-POCI-01-0145-FEDER-029284. Author Patrícia J.M. Reis was financially supported by a work contract, inserted in project PROMETHEUS-POCI-01-0145-FEDER-029284.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author. The data are not publicly available due to generation thereof from samples from a commercial manufacturer; the original data and their matching to batches, accordingly, requires prior discussion with company CEO prior to topical release.

Acknowledgments

Efstathios Z. Panagou is gratefully acknowledged for supply of Lactiplantibacillus pentosus B281, a part of the culture collection held by Laboratory of Microbiology and Biotechnology of Foods, Department of Food Science and Human Nutrition, Agricultural University of Athens.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hasler, C.M. Functional foods: Benefits, concerns and challenges—A position paper from the American Council on Science and Health. J. Nutr. 2002, 132, 3772–3781. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Prado, F.C.; Parada, J.L.; Pandey, A.; Soccol, C.R. Trends in non-dairy probiotic beverages. Food Res. Int. 2008, 41, 111–123. [Google Scholar] [CrossRef]
  3. Perpetuini, G.; Prete, R.; Garcia-Gonzalez, N.; Khairul Alam, M.; Corsetti, A. Table olives more than a fermented food. Foods 2020, 9, 178. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Margalho, L.P.; Jorge, G.P.; Noleto, D.A.P.; Silva, C.E.; Abreu, J.S.; Piran, M.V.F.; Brocchi, M.; Sant’Ana, A.S. Biopreservation and probiotic potential of a large set of lactic acid bacteria isolated from Brazilian artisanal cheeses: From screening to in product approach. Microbiol. Res. 2021, 242, 126622. [Google Scholar] [CrossRef]
  5. Casarotti, S.N.; Carneiro, B.M.; Todorov, S.D.; Nero, L.A.; Rahal, P.; Penna, A.L.B. In vitro assessment of safety and probiotic potential characteristics of Lactobacillus strains isolated from water buffalo mozzarella cheese. Ann. Microbiol. 2017, 67, 289–301. [Google Scholar] [CrossRef] [Green Version]
  6. Speranza, B.; Racioppo, A.; Beneduce, L.; Bevilacqua, A.; Sinigaglia, M.; Corbo, M.R. Autochthonous lactic acid bacteria with probiotic aptitudes as starter cultures for fish-based products. Food Microbiol. 2017, 65, 244–253. [Google Scholar] [CrossRef] [PubMed]
  7. Kumar, S.; Rattu, G.; Mitharwal, S.; Chandra, A.; Kumar, S.; Kaushik, A.; Mishra, V.; Nema, P.K. Trends in non-dairy-based probiotic food products: Advances and challenges. J. Food Process. Preserv. 2022, 46, 16578. [Google Scholar] [CrossRef]
  8. Bonatsou, S.; Tassou, C.C.; Panagou, E.Z.; Nychas, G.E. Table olive fermentation using starter cultures with multifunctional potential. Microorganisms 2017, 5, 30. [Google Scholar] [CrossRef] [Green Version]
  9. Sacchi, R.; Corrado, G.; Basile, B.; Mandarello, D.; Ambrosino, M.L.; Paduano, A.; Savarese, M.; Caporaso, N.; Aponte, M.; Genovese, A. Effect of salt addition and fermentation time on phenolics, microbial dynamics, volatile organic compounds, and sensory properties of the PDO table olives of Gaeta (Italy). Molecules 2022, 27, 8100. [Google Scholar] [CrossRef]
  10. Agagunduz, D.; Yilmaz, B.; Kocak, T.; Altintas Basar, H.B.; Rocha, J.M.; Ozogul, F. Novel candidate microorganisms for fermentation technology: From potential benefits to safety issues. Foods 2022, 11, 3074. [Google Scholar] [CrossRef]
  11. Georgieva, M.; Georgiev, K.; Hvarchanova, N. Chapter 29—Probiotics: Past, present, and future challenges. In Probiotics in the Prevention and Management of Human Diseases; Dwivedi, M.K., Amaresan, N., Sankaranarayanan, A., Kemp, E.H., Eds.; Academic Press: Cambridge, MA, USA, 2022; pp. 431–448. [Google Scholar]
  12. Reboredo-Rodriguez, P.; Gonzalez-Barreiro, C.; Martinez-Carballo, E.; Cambeiro-Perez, N.; Rial-Otero, R.; Figueiredo-Gonzalez, M.; Cancho-Grande, B. Applicability of an in-vitro digestion model to assess the bioaccessibility of phenolic compounds from olive-related products. Molecules 2021, 26, 6667. [Google Scholar] [CrossRef] [PubMed]
  13. Lucena-Padros, H.; Jimenez, E.; Maldonado-Barragan, A.; Rodriguez, J.M.; Ruiz-Barba, J.L. PCR-DGGE assessment of the bacterial diversity in Spanish-style green table-olive fermentations. Int. J. Food Microbiol. 2015, 205, 47–53. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Doulgeraki, A.I.; Pramateftaki, P.; Argyri, A.A.; Nychas, G.-J.E.; Tassou, C.C.; Panagou, E.Z. Molecular characterization of lactic acid bacteria isolated from industrially fermented Greek table olives. LWT Food Sci. Technol. 2013, 50, 353–356. [Google Scholar] [CrossRef]
  15. Comunian, R.; Ferrocino, I.; Paba, A.; Daga, E.; Campus, M.; Di Salvo, R.; Cauli, E.; Piras, F.; Zurru, R.; Cocolin, L. Evolution of microbiota during spontaneous and inoculated Tonda di Cagliari table olives fermentation and impact on sensory characteristics. LWT Food Sci. Technol. 2017, 84, 64–72. [Google Scholar] [CrossRef]
  16. Portilha-Cunha, M.F.; Macedo, A.C.; Malcata, F.X. A review on adventitious lactic acid bacteria from table olives. Foods 2020, 9, 948. [Google Scholar] [CrossRef]
  17. Abouloifa, H.; Rokni, Y.; Bellaouchi, R.; Ghabbour, N.; Karboune, S.; Brasca, M.; Ben Salah, R.; Chihib, N.; Saalaoui, E.; Asehraou, A. Characterization of probiotic properties of antifungal Lactobacillus strains isolated from traditional fermenting green olives. Probiotics Antimicrob. Proteins 2020, 12, 683–696. [Google Scholar] [CrossRef] [PubMed]
  18. Peres, C.M.; Alves, M.; Hernandez-Mendoza, A.; Moreira, L.; Silva, S.; Bronze, M.R.; Vilas-Boas, L.; Peres, C.; Malcata, F.X. Novel isolates of lactobacilli from fermented Portuguese olive as potential probiotics. LWT Food Sci. Technol. 2014, 59, 234–246. [Google Scholar] [CrossRef] [Green Version]
  19. Pereira, E.L.; Ramalhosa, E.; Borges, A.; Pereira, J.A.; Baptista, P. YEAST dynamics during the natural fermentation process of table olives (Negrinha de Freixo cv.). Food Microbiol. 2015, 46, 582–586. [Google Scholar] [CrossRef] [Green Version]
  20. Oliveira, T.; Ramalhosa, E.; Nunes, L.; Pereira, J.A.; Colla, E.; Pereira, E.L. Probiotic potential of indigenous yeasts isolated during the fermentation of table olives from Northeast of Portugal. Innov. Food. Sci. Emerg. Technol. 2017, 44, 167–172. [Google Scholar] [CrossRef] [Green Version]
  21. Albuquerque, T.G.; Costa, H.S.; Oliveira, M.B.P.P. An overview of Portuguese olive oils and table olives with Protected Designation of Origin. Eur. J. Lipid Sci. Technol. 2019, 121, 1800129. [Google Scholar] [CrossRef]
  22. Pineiro, M.; Stanton, C. Probiotic bacteria: Legislative framework—Requirements to evidence basis. J. Nutr. 2007, 137, 850S–853S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Government of Canada. Accepted Claims about the Nature of Probiotic Microorganisms in Food—Food Labelling—Health Canada. Available online: http://www.hc-sc.gc.ca/fn-an/label-etiquet/claims-reclam/probiotics_claims-allegations_probiotiques-eng.php (accessed on 29 March 2023).
  24. Reis, P.J.M.; Tavares, T.G.; Rocha, J.M.; Malcata, F.X.; Macedo, A.C. Cobrançosa table olives: Characterization of processing method and lactic acid bacteria profile throughout spontaneous fermentation. Appl. Sci. 2022, 12, 9738. [Google Scholar] [CrossRef]
  25. Luz, C.; Calpe, J.; Manuel Quiles, J.; Torrijos, R.; Vento, M.; Gormaz, M.; Mañes, J.; Meca, G. Probiotic characterization of Lactobacillus strains isolated from breast milk and employment for the elaboration of a fermented milk product. J. Funct. Foods 2021, 84, 104599. [Google Scholar] [CrossRef]
  26. Maragkoudakis, P.A.; Zoumpopoulou, G.; Miaris, C.; Kalantzopoulos, G.; Pot, B.; Tsakalidou, E. Probiotic potential of Lactobacillus strains isolated from dairy products. Int. Dairy J. 2006, 16, 189–199. [Google Scholar] [CrossRef]
  27. Nath, S.; Sikidar, J.; Roy, M.; Deb, B. In vitro screening of probiotic properties of Lactobacillus plantarum isolated from fermented milk product. Food Qual. Saf. 2020, 4, 213–223. [Google Scholar] [CrossRef]
  28. Ozkan, E.R.; Demirci, T.; Ozturk, H.I.; Akin, N. Screening Lactobacillus strains from artisanal Turkish goatskin casing Tulum cheeses produced by nomads via molecular and in vitro probiotic characteristics. J. Sci. Food Agric. 2020, 101, 2799–2808. [Google Scholar] [CrossRef]
  29. Benítez-Cabello, A.; Torres-Maravilla, E.; Bermudez-Humaran, L.; Langella, P.; Martin, R.; Jimenez-Diaz, R.; Arroyo-Lopez, F.N. Probiotic properties of Lactobacillus strains isolated from table olive biofilms. Probiotics Antimicrob. Proteins 2020, 12, 1071–1082. [Google Scholar] [CrossRef]
  30. Motey, G.A.; Owusu-Kwarteng, J.; Obiri-Danso, K.; Ofori, L.A.; Ellis, W.O.; Jespersen, L. In vitro properties of potential probiotic lactic acid bacteria originating from Ghanaian indigenous fermented milk products. World J. Microbiol. Biotechnol. 2021, 37, 52. [Google Scholar] [CrossRef]
  31. Joghataei, M.; Shahidi, F.; Pouladfar, G.; Mortazavi, S.A.; Ghaderi, A. Probiotic potential comparison of Lactobacillus strains isolated from Iranian traditional food products and human feces with standard probiotic strains. J. Sci. Food Agric. 2019, 99, 6680–6688. [Google Scholar] [CrossRef]
  32. Rashmi, B.S.; Gayathri, D. Molecular characterization of gluten hydrolysing Bacillus sp. and their efficacy and biotherapeutic potential as probiotics using Caco-2 cell line. J. Appl. Microbiol. 2017, 123, 759–772. [Google Scholar] [CrossRef]
  33. Zullo, B.A.; Ciafardini, G. Evaluation of physiological properties of yeast strains isolated from olive oil and their in vitro probiotic trait. Food Microbiol. 2019, 78, 179–187. [Google Scholar] [CrossRef] [PubMed]
  34. Sakandar, H.A.; Kubow, S.; Sadiq, F.A. Isolation and in-vitro probiotic characterization of fructophilic lactic acid bacteria from Chinese fruits and flowers. LWT Food Sci. Technol. 2019, 104, 70–75. [Google Scholar] [CrossRef]
  35. Bonatsou, S.; Karamouza, M.; Zoumpopoulou, G.; Mavrogonatou, E.; Kletsas, D.; Papadimitriou, K.; Tsakalidou, E.; Nychas, G.E.; Panagou, E. Evaluating the probiotic potential and technological characteristics of yeasts implicated in cv. Kalamata natural black olive fermentation. Int. J. Microbiol. 2018, 271, 48–59. [Google Scholar] [CrossRef] [PubMed]
  36. de Melo Pereira, G.V.; de Oliveira Coelho, B.; Magalhaes Junior, A.I.; Thomaz-Soccol, V.; Soccol, C.R. How to select a probiotic? A review and update of methods and criteria. Biotechnol. Adv. 2018, 36, 2060–2076. [Google Scholar] [CrossRef] [PubMed]
  37. Li, M.; Wang, Y.; Cui, H.; Li, Y.; Sun, Y.; Qiu, H.J. Characterization of lactic acid bacteria isolated from the gastrointestinal tract of a wild boar as potential probiotics. Front. Vet. Sci. 2020, 7, 49. [Google Scholar] [CrossRef] [Green Version]
  38. Jørgensen, M.R.; Kragelund, C.; Jensen, P.Ø.; Keller, M.K.; Twetman, S. Probiotic Lactobacillus reuteri has antifungal effects on oral Candida species in vitro. J. Oral Microbiol. 2017, 9, 1274582. [Google Scholar] [CrossRef]
  39. Zarour, K.; Prieto, A.; Pérez-Ramos, A.; Kihal, M.; López, P. Analysis of technological and probiotic properties of Algerian L. mesenteroides strains isolated from dairy and non-dairy products. J. Funct. Foods 2018, 49, 351–361. [Google Scholar] [CrossRef]
  40. Vergalito, F.; Testa, B.; Cozzolino, A.; Letizia, F.; Succi, M.; Lombardi, S.J.; Tremonte, P.; Pannella, G.; Di Marco, R.; Sorrentino, E.; et al. Potential application of Apilactobacillus kunkeei for human use: Evaluation of probiotic and functional properties. Foods 2020, 9, 1535. [Google Scholar] [CrossRef]
  41. Pavli, F.; Gkana, E.; Adebambo, O.; Karatzas, K.A.; Panagou, E.; Nychas, G.E. In vitro screening of gamma-aminobutyric acid and autoinducer-2 signalling in lactic acid bacteria exhibiting probiotic potential isolated from natural black Conservolea olives. Foods 2019, 8, 640. [Google Scholar] [CrossRef] [Green Version]
  42. Ayyash, M.; Al-Nuaimi, A.K.; Al-Mahadin, S.; Liu, S.Q. In vitro investigation of anticancer and ACE-inhibiting activity, alpha-amylase and alpha-glucosidase inhibition, and antioxidant activity of camel milk fermented with camel milk probiotic: A comparative study with fermented bovine milk. Food Chem. 2018, 239, 588–597. [Google Scholar] [CrossRef]
  43. Abouloifa, H.; Hasnaoui, I.; Rokni, Y.; Bellaouchi, R.; Gaamouche, S.; Ghabbour, N.; Chaoui, J.; Brasca, M.; Karboune, S.; Ben Salah, R.; et al. Technological properties of potential probiotic Lactobacillus strains isolated from traditional fermenting green olive. J. Microbiol. Biotechnol. Food Sci. 2020, 9, 884–889. [Google Scholar] [CrossRef]
  44. Pacularu-Burada, B.; Georgescu, L.A.; Vasile, M.A.; Rocha, J.M.; Bahrim, G.E. Selection of wild lactic acid bacteria strains as promoters of postbiotics in gluten-free sourdoughs. Microorganisms 2020, 8, 643. [Google Scholar] [CrossRef]
  45. Iorizzo, M.; Lombardi, S.J.; Macciola, V.; Testa, B.; Lustrato, G.; Lopez, F.; De Leonardis, A. Technological potential of Lactobacillus strains isolated from fermented green olives: In vitro studies with emphasis on oleuropein-degrading capability. Sci. World J. 2016, 2016, 1917592. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Benítez-Cabello, A.; Calero-Delgado, B.; Rodriguez-Gomez, F.; Garrido-Fernandez, A.; Jimenez-Diaz, R.; Arroyo-Lopez, F.N. Biodiversity and multifunctional features of lactic acid bacteria isolated from table olive biofilms. Front. Microbiol. 2019, 10, 836. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Gulshan, A.; Lee, B.H.; Lamoureux, M. Characterization of enzyme profiles of Lactobacillus casei species by a Rapid API ZYM System. Int. J. Dairy Sci. 1990, 2, 264–273. [Google Scholar] [CrossRef]
  48. Domingos-Lopes, M.F.P.; Stanton, C.; Ross, P.R.; Dapkevicius, M.L.E.; Silva, C.C.G. Genetic diversity, safety and technological characterization of lactic acid bacteria isolated from artisanal Pico cheese. Food Microbiol. 2017, 63, 178–190. [Google Scholar] [CrossRef]
  49. Delgado, S.; O’Sullivan, E.; Fitzgerald, G.; Mayo, B. Subtractive screening for probiotic properties of Lactobacillus species from the human gastrointestinal tract in the search for new probiotics. J. Food Sci. 2007, 72, 310–315. [Google Scholar] [CrossRef]
  50. Coimbra-Gomes, J.; Reis, P.J.M.; Tavares, T.G.; Silva, A.A.; Mendes, E.; Casal, S.; Malcata, F.X.; Macedo, A.C. Cobrançosa table olive fermentation as per the Portuguese traditional method, using potentially probiotic Lactiplantibacillus pentosus i106 upon alternative inoculation strategies. Fermentation 2022, 9, 12. [Google Scholar] [CrossRef]
  51. Coimbra-Gomes, J.; Reis, P.J.M.; Tavares, T.G.; Malcata, F.X.; Macedo, A.C. Study of lactic acid bacteria biodiversity in fermented Cobrançosa table olives to determine their probiotic potential. Foods 2022, 11, 3050. [Google Scholar] [CrossRef]
  52. Argyri, A.A.; Zoumpopoulou, G.; Karatzas, K.A.; Tsakalidou, E.; Nychas, G.J.; Panagou, E.Z.; Tassou, C.C. Selection of potential probiotic lactic acid bacteria from fermented olives by in vitro tests. Food Microbiol. 2013, 33, 282–291. [Google Scholar] [CrossRef]
  53. Montoro, B.P.; Benomar, N.; Lavilla Lerma, L.; Castillo Gutierrez, S.; Galvez, A.; Abriouel, H. Fermented Alorena table olives as a source of potential probiotic Lactobacillus pentosus strains. Front. Microbiol. 2016, 7, 1583. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Taheur, B.F.; Kouidhi, B.; Fdhila, K.; Elabed, H.; Ben Slama, R.; Mahdouani, K.; Bakhrouf, A.; Chaieb, K. Anti-bacterial and anti-biofilm activity of probiotic bacteria against oral pathogens. Microb. Pathog. 2016, 97, 213–220. [Google Scholar] [CrossRef] [PubMed]
  55. Szutowska, J.; Gwiazdowska, D. Probiotic potential of lactic acid bacteria obtained from fermented curly kale juice. Arch. Microbiol. 2020, 203, 975–988. [Google Scholar] [CrossRef] [PubMed]
  56. Abouloifa, H.; Khodaei, N.; Rokni, Y.; Karboune, S.; Brasca, M.; D’Hallewin, G.; Salah, R.B.; Saalaoui, E.; Asehraou, A. The prebiotics (Fructo-oligosaccharides and Xylo-oligosaccharides) modulate the probiotic properties of Lactiplantibacillus and Levilactobacillus strains isolated from traditional fermented olive. World J. Microbiol. Biotechnol. 2020, 36, 185. [Google Scholar] [CrossRef] [PubMed]
  57. Mulaw, G.; Sisay Tessema, T.; Muleta, D.; Tesfaye, A. In vitro evaluation of probiotic properties of lactic acid bacteria isolated from some traditionally fermented Ethiopian food products. Int. J. Microbiol. 2019, 2019, 7179514. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Anagnostopoulos, D.; Bozoudi, D.; Tsaltas, D. Enterococci Isolated from Cypriot green table olives as a new source of technological and probiotic properties. Fermentation 2018, 4, 48. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Plot of communalities from component extraction method, pertaining to probiotic characteristics associated with gastrointestinal tract.
Figure 1. Plot of communalities from component extraction method, pertaining to probiotic characteristics associated with gastrointestinal tract.
Molecules 28 03285 g001
Figure 2. (a) Plot of loadings formed by first two principal components from Principal Component Analysis, pertaining to probiotic characteristics associated with gastrointestinal tract and RAPD profile; and (b) plot of scores encompassing strains isolated from Cobrançosa table olives.
Figure 2. (a) Plot of loadings formed by first two principal components from Principal Component Analysis, pertaining to probiotic characteristics associated with gastrointestinal tract and RAPD profile; and (b) plot of scores encompassing strains isolated from Cobrançosa table olives.
Molecules 28 03285 g002
Figure 3. (a) Plot of loadings formed by first two principal components from Principal Component Analysis, pertaining to probiotic characteristics associated with gastrointestinal tract and time of processing; and (b) plot of scores encompassing strains from Cobrançosa LAB table olives.
Figure 3. (a) Plot of loadings formed by first two principal components from Principal Component Analysis, pertaining to probiotic characteristics associated with gastrointestinal tract and time of processing; and (b) plot of scores encompassing strains from Cobrançosa LAB table olives.
Molecules 28 03285 g003
Table 1. Identification of native strains isolated from Cobrançosa table olives.
Table 1. Identification of native strains isolated from Cobrançosa table olives.
SpeciesIsolate IDTime of Process (d)Producer IDTank IDRAPD Profile
L. paraplantarumi19166A2lpa01
i21140H2lpa06
i24111A1lpa01
i26166A1lpa01
i101111A2lpa01
i112111A2lpa01
L. pentosusi17111A2lpe205a
i22166A1lpe205a
i23166A1lpe205a
i32166A2lpe308
i34166A2lpe308
i53329A2lpe104
i106329A1lpe205b
i108329A1lpe308
Table 2. Performance of L. pentosus and L. paraplantarum strains pertaining to Caco-cell adhesion, hydrophobicity, and autoaggregation.
Table 2. Performance of L. pentosus and L. paraplantarum strains pertaining to Caco-cell adhesion, hydrophobicity, and autoaggregation.
IsolatesAdhesion
(% ± SD) *
Hydrophocity
(% ± SD) *
Autoaggregation (% ± SD) *
5 h24 h
L. paraplantarum
i1911.67 ± 2.57 efg15.79 ± 1.34 de32.44 ± 4.0392.86 ± 8.20 ab
i216.20 ± 0.96 hi55.99 ± 1.91 a23.71 ± 4.9279.80 ± 5.50 abcd
i245.30 ± 0.75 i21.58 ± 6.67 cde25.27 ± 6.3688.69 ± 6.22 abcd
i268.37 ± 0.65 ghi34.13 ± 6.08 bc19.02 ± 4.4992.11 ± 4.95 abc
i10118.40 ± 1.10 bc19.34 ± 1.08 de25.31 ± 5.5388.11 ± 6.42 abcd
i11215.80 ± 0.36 cd19.46 ± 5.99 de23.21 ± 4.0190.33 ± 6.44 abcd
L. pentosus
i1713.83 ± 2.12 de26.42 ± 4.66 bcde24.21 ± 11.0383.57 ± 11.18 abcd
i2212.20 ± 0.36 def23.50 ± 3.82 cde26.73 ± 8.3259.39 ± 8.15 d
i2315.97 ± 1.27 cd21.85 ± 4.91 cde29.15 ± 6.0488.87 ± 4.21 abcd
i326.00 ± 0.46 hi40.80 ± 3.76 b23.67 ± 0.0878.82 ± 7.98 abcd
i341.07 ± 0.38 ij20.97 ± 7.55 cde19.63 ± 2.1781.09 ± 5.40 abcd
i5322.23 ± 2.21 ab21.63 ± 7.79 cde31.36 ± 8.8192.98 ± 3.04 a
i10623.03 ± 1.72 a21.54 ± 1.44 cde24.91 ± 9.3888.52 ± 4.47 abcd
i1084.80 ± 1.50 ij20.78 ± 3.37 de22.37 ± 1.0980.05 ± 4.35 abcd
Reference strains **
commercial yoghurt9.86 ± 1.01 fgh27.39 ± 4.75 bcde23.51 ± 1.3278.92 ± 5.25 abcd
Greek olives21.03 ± 0.15 ab32.26 ± 4.60 bcd26.12 ± 1.2771.66 ± 4.64 d
ANOVA
p-value0.0000.0000.3540.005
* Values are given as means ± SD of data from replicate experiments. Values in the same column with different superscript letters differ significantly (p < 0.05). ** Lacticaseibacillus casei isolated from commercial yoghurt; Lactiplantibacillus pentosus B281 isolated from Greek table olives [8].
Table 3. Performance of L. pentosus and L. paraplantarum strains pertaining to co-aggregation with pathogens.
Table 3. Performance of L. pentosus and L. paraplantarum strains pertaining to co-aggregation with pathogens.
IsolatesCo-Aggregation (% ± SD) *
Gram PositiveGram−NegativeYeast
B. cereus
ATCC 11778
S. aureus
ATCC 25923
Ent. faecalis
ATCC 29212
L. innocua
ATCC 33090
S. enteritidis
ATCC 25928
E. coli
ATCC 25922
C. albicans
ATCC 0231
L. paraplantarum
i1937.11 ± 8.2039.24 ± 9.7741.76 ± 4.3634.37 ± 4.8029.94 ± 4.7129.07 ± 11.4545.25 ± 8.85
i2126.67 ± 11.1631.35 ± 9.9531.65 ± 5.1138.00 ± 2.6522.06 ± 8.8329.84 ± 10.2437.02 ± 5.92
i2429.94 ± 13.7232.01 ± 10.2541.80 ± 1.4639.18 ± 1.5730.42 ± 7.5235.22 ± 11.2742.44 ± 3.99
i2634.92 ± 14.2241.62 ± 9.6239.90 ± 1.3330.24 ± 4.5032.63 ± 17.0331.52 ± 14.1945.95 ± 9.03
i10134.33 ± 8.6434.73 ± 11.3937.33 ± 5.9134.81 ± 1.2734.12± 4.2633.39 ± 7.2242.86 ± 5.64
i11228.58 ± 12.1034.59 ± 4.7738.67 ± 5.7133.82 ± 3.5532.73 ± 6.5727.15 ± 8.5637.49 ± 2.21
L. pentosus
i1730.67 ± 6.2322.94 ± 8.2330.66 ± 6.5835.03 ± 6.9021.23 ±9.5222.56 ±6.0735.44 ± 3.44
i2233.27 ± 8.0137.30 ± 2.7137.78 ± 6.5333.29 ± 7.7724.37 ± 4.8637.10 ± 10.6940.24 ± 1.60
i2331.87 ± 12.6532.53 ± 15.8436.84 ± 9.0240.95 ± 1.2532.60 ± 13.4328.35 ± 15.4240.64 ± 5.01
i3230.41 ± 8.1828.86 ± 7.4245.02 ± 6.4134.95 ± 2.3428.14 ± 11.3528.88 ± 6.4844.64 ± 6.22
i3433.66 ± 16.3139.82 ± 3.9142.12 ± 4.0038.34 ± 8.3435.59 ± 6.6640.78 ± 4.9645.01 ± 4.78
i5336.59 ± 10.0024.66 ± 2.5838.26 ± 7.6739.89 ± 5.7815.67 ± 5.7832.82 ± 7.9644.28 ± 5.63
i10634.05 ± 6.9829.45 ± 4.6538.53 ± 12.5038.13 ± 0.5625.27 ± 6.9828.58 ± 10.9039.39 ± 2.98
i10830.03 ± 7.0534.66 ± 10.5438.17 ± 1.5036.75 ± 10.6824.54 ± 4.6332.34 ± 5.2040.94 ± 2.94
Reference strains **
commercial yoghurt40.84 ± 8.5639.26 ± 0.2736.04 ± 0.3936.57 ± 4.8931.04 ± 3.4935.39 ± 7.0842.77 ± 4.06
Greek olives41.13 ± 2.3036.91 ± 8.5635.82 ± 8.3535.90 ± 5.5135.56 ± 9.1337.48 ± 6.3744.93 ± 5.83
ANOVA
p-value0.9320.7610.4470.6580.2110.3140.373
* Values are given as means ± SD of data from replicate experiments. ** Lacticaseibacillus casei isolated from commercial yoghurt; Lactiplantibacillus pentosus B281 isolated from Greek table olives [8].
Table 4. Performance of L. pentosus and L. paraplantarum strains pertaining to antibiotic resistance.
Table 4. Performance of L. pentosus and L. paraplantarum strains pertaining to antibiotic resistance.
IsolatesAntibiotic Resistance (mm) *
AMPETEVAOFXCSKF
L. paraplantarum
i1938 (S)29 (S)25 (S)0 (R)0 (R)33 (S)0 (R)27 (S)
i2140 (S)29 (S)25 (S)0 (R)0 (R)29 (S)0 (R)24 (S)
i2445 (S)25 (S)28 (S)0 (R)0 (R)34 (S)0 (R)45 (S)
i2638 (S)27 (S)28 (S)0 (R)0 (R)29 (S)0 (R)26 (S)
i10135 (S)26 (S)26 (S)0 (R)0 (R)33 (S)0 (R)22 (S)
i11242 (S)27 (S)29 (S)0 (R)16 (I)33 (S)0 (R)40 (S)
L. pentosus
i1735 (S)29 (S)24 (S)0 (R)0 (R)32 (S)0 (R)25 (S)
i2248 (S)29 (S)24 (S)0 (R)0 (R)32 (S)0 (R)37 (S)
i2340 (S)26 (S)21 (S)0 (R)0 (R)39 (S)0 (R)35 (S)
i3241 (S)30 (S)26 (S)0 (R)0 (R)32 (S)0 (R)30 (S)
i3434 (S)27 (S)24 (S)0 (R)0 (R)34 (S)0 (R)28 (S)
i5339 (S)27 (S)25 (S)0 (R)0 (R)31 (S)0 (R)44 (S)
i10641 (S)27 (S)25 (S)0 (R)0 (R)34 (S)0 (R)47 (S)
i10845 (S)25 (S)24 (S)0 (R)0 (R)37 (S)0 (R)47 (S)
Reference strains **
commercial yoghurt36 (S)35 (S)35 (S)0 (R)13 (I)33 (S)0 (R)32 (S)
Greek olives32 (S)28 (S)26 (S)0 (R)0 (R)28 (S)0 (R)22 (S)
* (R) Resistant: ≤14 mm; (I) Intermediate resistant: 15–19 mm; (S) Susceptible: ≥20 mm; AMP: ampicillin; E: erythromycin; TE: tetracycline; VA: vancomycin; OFX: ofloxacin; C: chloramphenicol; S: streptomycin; KF: cephalothin. ** Lacticaseibacillus casei isolated from commercial yoghurt; Lactiplantibacillus pentosus B281 isolated from Greek olives [8].
Table 5. Performance of L. pentosus and L. paraplantarum strains pertaining to antioxidant activity, cholesterol assimilation, proteolytic activity, and EPS production.
Table 5. Performance of L. pentosus and L. paraplantarum strains pertaining to antioxidant activity, cholesterol assimilation, proteolytic activity, and EPS production.
IsolatesAntioxidant Activity
(% ± SD) *
Cholesterol
Assimilation
(% ± SD) *
Proteolytic
Activity **
EPS
Production **
L. paraplantarum
i1923.00 ± 0.89 a78.64 ± 1.60 abc+
i2120.10 ± 2.79 ab75.42 ± 0.67 abcd++
i2420.20 ± 3.40 ab70.65 ± 4.37 de+
i2622.27 ± 2.44 ab75.72 ± 3.12 abcd+
i10120.47 ± 1.95 ab74.35 ± 1.23 bcde+
i11218.03 ± 2.91 abc77.34 ± 1.51 abcd+
L. pentosus
i1720.90 ± 0.56 ab73.72 ± 4.09 bcde++
i2218.77 ± 0.06 bc75.68 ± 2.73 abcd++
i2317.47 ± 2.14 bcd81.51 ± 0.09 a++
i3220.27 ± 1.07 ab67.87 ± 0.69 e+
i3421.73 ± 1.17 ab77.62 ± 1.01 abc++
i5319.90 ± 0.72 ab79.83 ± 2.59 ab++
i10619.60 ± 1.75 ab77.45 ± 0.54 abc++
i10820.97 ± 2.35 ab72.20 ± 0.89 cde++
Reference strains ***
commercial yoghurt17.77 ± 1.67 bc52.27 ± 3.17 f++
Greek olives13.27 ± 1.65 cd76.54 ± 1.23 abcd++
ANOVA
p-value0.0000.000
* Values are given as means ± SD of data from triplicate experiments. Values in the same column with different superscript letters differ significantly (p < 0.05). ** (+) positive result; (−) negative result. *** Lacticaseibacillus casei isolated from commercial yoghurt; Lactiplantibacillus pentosus B281 isolated from Greek olives [8].
Table 6. Performance of L. pentosus and L. paraplantarum strains pertaining to enzymatic activities.
Table 6. Performance of L. pentosus and L. paraplantarum strains pertaining to enzymatic activities.
Detected Enzyme *L. paraplantarumL. pentosusReference Strains **
i19i21i24i26i101i111i17i22i23i32i34i53i106i108Commercial YoghurtGreek Olives
Alkaline phosphatase1211110001000100
Esterase3333331113121341
Lipase esterase3333331113121341
Lipase0000000000000000
Leucine arylamidase4544443334353553
Valine arylamidase4444444444454554
Cystine arylamidase0300000000000030
Trypsin0000000000000000
α-chymotrypsin0000000000000000
Acid phosphatase4544443334343443
Naphthol-AS-BI-phosphohydrolase4544444444444454
α-galactosidase0200001110101001
β-galactosidase3533335553545445
β-glucuronidase0000000000000000
α-glucosidase3333335553555555
β-glucosidase5455553335343414
N-acetil-β-glucosaminidase0000000000000000
α-manosidase0000000000000000
α-fucosidase0000000000000000
* Scale of API-ZYM® (bioMÉRIEUX, Craponne, France) test used for enzyme quantification: 0 corresponding to “no activity”; 1 corresponding to 5 nmol substrate metabolized and 2 to 10 nmol: “low activity”; 3 corresponding to 20 nmol, 4 to 30 nmol, and 5 to 40 nmol: “high activity”. ** Lacticaseibacillus casei isolated from commercial yoghurt; Lactiplantibacillus pentosus B281 isolated from Greek olives [8].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Coimbra-Gomes, J.; Reis, P.J.M.; Tavares, T.G.; Faria, M.A.; Malcata, F.X.; Macedo, A.C. Evaluating the Probiotic Potential of Lactic Acid Bacteria Implicated in Natural Fermentation of Table Olives, cv. Cobrançosa. Molecules 2023, 28, 3285. https://doi.org/10.3390/molecules28083285

AMA Style

Coimbra-Gomes J, Reis PJM, Tavares TG, Faria MA, Malcata FX, Macedo AC. Evaluating the Probiotic Potential of Lactic Acid Bacteria Implicated in Natural Fermentation of Table Olives, cv. Cobrançosa. Molecules. 2023; 28(8):3285. https://doi.org/10.3390/molecules28083285

Chicago/Turabian Style

Coimbra-Gomes, Joana, Patrícia J. M. Reis, Tânia G. Tavares, Miguel A. Faria, F. Xavier Malcata, and Angela C. Macedo. 2023. "Evaluating the Probiotic Potential of Lactic Acid Bacteria Implicated in Natural Fermentation of Table Olives, cv. Cobrançosa" Molecules 28, no. 8: 3285. https://doi.org/10.3390/molecules28083285

APA Style

Coimbra-Gomes, J., Reis, P. J. M., Tavares, T. G., Faria, M. A., Malcata, F. X., & Macedo, A. C. (2023). Evaluating the Probiotic Potential of Lactic Acid Bacteria Implicated in Natural Fermentation of Table Olives, cv. Cobrançosa. Molecules, 28(8), 3285. https://doi.org/10.3390/molecules28083285

Article Metrics

Back to TopTop